Saura, C., Tseng, L., Chan, S., Chacko, R., Campone, M., Manikhas, A., . . . Pusztai, L. (2013). Neoadjuvant doxorubicin/cyclophosphamide followed by ixabepilone or paclitaxel in early stage breast cancer and evaluation of beta III-Tubulin expression as a predictive marker.
Citación estilo ChicagoSaura, Cristina, et al. Neoadjuvant Doxorubicin/cyclophosphamide Followed By Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of Beta III-Tubulin Expression As a Predictive Marker. 2013.
Cita MLASaura, Cristina, et al. Neoadjuvant Doxorubicin/cyclophosphamide Followed By Ixabepilone or Paclitaxel in Early Stage Breast Cancer and Evaluation of Beta III-Tubulin Expression As a Predictive Marker. 2013.
Precaución: Estas citas no son 100% exactas.
